Background: Expression of programmed death 1 (PD-1) is upregulated on CD4+ and CD8+ T cells in untreated HIV infection, resulting in decreased proliferation and function. The impact of antiretroviral treatment (ART) and the determinants of PD-1 expression in CD4+ and CD8+ T cells are not fully understood. Methodology: We assessed T cell expression of PD-1 longitudinally in a cohort of acutely infected HIV+ individuals who started ART early (6 months) vs. late (2 years after infection) and cross-sectionally in a diverse cohort of chronically HIV-infected adults, including elite controllers and long-term immunologic non-responders (INRs; individuals who failed to achieve a CD4+ T cell count >350 cells/mm3 on long-term ART). PD-1 MFI was measured by flow cytometry on total CD4+ and CD8+ T cells and T cell subsets. Longitudinal mixed effects regression modeling was done to assess the impact of ART and other factors on PD-1 expression. Results: In the longitudinal cohort (n=121), PD-1 expression increased an average of 6.4% and 7.9% each year without ART on CD4+ and CD8+ T cells, respectively. Early ART initiation resulted in a rapid decline in PD-1 expression on CD8+ T cells (41% after one year of ART, P <0.001); similar results were observed in CD4+ T cells. Delayed ART resulted in a similar decline in PD-1 expression. In the cross-sectional cohort (n=206), PD-1 expression remained high in INRs (median MFI of 218 vs. 130 in responders vs. NRs, P <0.001). This effect was seen in all T cell memory subsets. Compared to HIV-uninfected, elite controllers had similar PD-1 expression on both total CD4+ and CD8+ T cells, while viremic controllers had higher PD-1 on effector memory CD8+ T cells (P = 0.03). Amongst all ART suppressed subjects in both cohorts, PD-1 expression on CD4+ T cells was strongly associated with CD4+ T cell activation (ρ = 0.53, P <0.001) and inversely with CD4 count (ρ = -0.50, P < 0.001). In contrast, PD-1 expression on CD8+ T cells was most strongly associated with CD8+ T cell activation and plasma viral load in viremic subjects (CD8+ T cell activation: ρ = 0.60, P < 0.001; VL: ρ = 0.30, P = 0.01). Conclusions: PD-1 expression on CD4+ T cells is strongly associated with peripheral CD4+ T cell count and frequency of activated CD4+ T cells, while PD-1 expression on CD8+ T cells is associated with viremia and CD8+ T cell activation. Effective ART reduces PD-1 on both populations. Multiple mechanisms may account for the CD4+ T cell observations, including a potential role of homeostatic signals such as IL-7 causing proliferation and PD-1 expression. Prospective studies of anti-PD-1 antibody therapy will be needed to define whether PD-1 expression on CD4+ T cells is a cause or consequence of CD4+ T cell lymphopenia. Antigen-driven activation likely accounts for PD-1 expression on CD8+ T cells.